Discussion: Previously, the M1L, Q2K and S182Stop in the pre-S2 region and T105C in the pre-S/S region were reported as specific mutations in OBI patients.
A matched case-control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma.